[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-357411-105":59,"doc-detail-357411-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","proteomic-characterization-of-as1411-reveals-atp6ap1-as-a-mediator-of-triple-negative-breast-cancer-progression","Proteomic Characterization of AS1411 Reveals ATP6AP1 as a Mediator of Triple-Negative Breast Cancer Progression","","Triple-negative breast cancer (TNBC) remains an aggressive subtype with high metastatic potential, poor prognosis, and limited effective therapies. This study examines the anticancer mechanisms of the nucleolin (NCL)-targeting DNA aptamer AS1411 using label-free quantitative proteomics. AS1411 treatment lowers TNBC cell viability and migration, and global proteomic profiling identifies tumor-associated pathways and protein–protein networks altered by AS1411. ATP6AP1 is strongly downregulated; manipulating ATP6AP1 modulates proliferation, migration, and tumorigenic phenotypes with minimal impact on normal breast epithelial cells.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/proteomic-characterization-of-as1411-reveals-atp6ap1-as-a-mediator-of-triple-negative-breast-cancer-progression/357411/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/proteomic-characterization-of-as1411-reveals-atp6ap1-as-a-mediator-of-triple-negative-breast-cancer-progression/357411.png","ImageObject",300,407,{"name":92,"@type":93},"Bulrr","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main objective of this study on AS1411 and TNBC?","Question",{"text":112,"@type":113},"The study investigates the molecular mechanisms behind AS1411’s anticancer effects in triple-negative breast cancer using label-free quantitative proteomics.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does AS1411 affect TNBC cells according to the abstract?",{"text":117,"@type":113},"AS1411 treatment significantly reduces TNBC cell viability and migration.",{"name":119,"@type":110,"acceptedAnswer":120},"Why is ATP6AP1 important in the findings?",{"text":121,"@type":113},"ATP6AP1 is markedly downregulated after AS1411 treatment, and functional experiments show that altering ATP6AP1 expression suppresses or enhances TNBC proliferation and migration, supporting it as a key mediator.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},357411,1790308202,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},5909892115043,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Proteomics  \nRESEARCH ARTICLE   \nProteomic Characterization of AS1411 Reveals ATP6AP1 as a Mediator of Triple-Negative Breast Cancer Progression  \nHa-Song Bae1  Yun-Jeong Seo1  Eun-Bi Kim1  Hyoung-Min Park2   I-Hsuan Liu3   J. Eugene Lee2  Jae-Young Kim1   \n1 Graduate School of Analytical Science and Technology (GRAST), Chungnam National University, Daejeon, Republic of Korea  2 Biometrology group, Division of Biomedical Metrology, Korea Research Institute of Standards and Science, Daejeon, Republic of Korea  3 Department of Animal Science and Technology, National Taiwan University, Taipei City, Taiwan (R.O.C.)  \nCorrespondence: J. Eugene Lee (Jinhwan.lee@kriss.re.kr)  Jae-Young Kim ([jaeyoungkim@cnu.ac.kr](jaeyoungkim@cnu.ac.kr))  \nReceived: 18 August 2025  Revised: 12 February 2026  Accepted: 14 March 2026  \nKeywords: AS1411 | ATP6AP1 | proteomics | triple-negative breast cancer  \nABSTRACT  \nTriple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer characterized by high metastatic potential, poor prognosis, and limited effective therapeutic options. In this study, we investigated the molecular mechanisms underlying the anticancer effects of the nucleolin (NCL)-targeting DNA aptamer AS1411 using label-free quantitative proteomic profiling. AS1411 treatment significantly reduced TNBC cell viability and migration. To uncover the underlying mechanisms, we performed global proteomic analysis of AS1411-treated TNBC cells. Bioinformatic analysis of differentially expressed proteins (DEPs) revealed enrichment of tumor-associated signaling pathways and protein–protein interaction networks regulated by AS1411 . Among the DEPs, ATPase H+ -transporting accessory protein 1 (ATP6AP1) was markedly downregulated in AS1411-treated TNBC cells. Functional studies demonstrated that ATP6AP1 knockdown suppressed TNBC cell proliferation and migration, whereas its overexpression enhanced tumorigenic phenotypes. Importantly, modulation of ATP6AP1 expression showed minimal effects on normal breast epithelial cells. Collectively, these findings identify ATP6AP1 as a key downstream mediator of AS1411 and support its potential as a therapeutic target in TNBC.  \n1  Introduction  \nBreast cancer, one of the most common malignant tumors affecting women, accounts for 32% of all new cancer cases in 2024, with an estimated 313,510 new diagnoses [1, 2] . Clinically, breast cancer is classified into four major molecular subtypes: luminal A, luminal B, HER2-enriched, and triple-negative breast cancer (TNBC) [3, 4]. TNBC is characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and HER2 expression. It is associated with a high risk of metastasis, poor prognosis, and  \nlimited treatment options, making it one of the most challenging subtypes to treat.  \nNucleolin (NCL) is a multifunctional protein primarily localized in the nucleolus, where it plays a central role in ribosomal RNA (rRNA) transcription and ribosome assembly [5] . In the nucleolus, NCL contributes to RNA processing, including rRNA transcription and ribosomal subunit preassembly. In contrast, cytoplasmic NCL has been implicated in diverse cellular processes such as endocytosis, cell cycle regulation, and tumor  \n\n| Abbreviations: ATP6AP1, ATPase H+-transporting accessory protein 1; DEPs, Differentially expressed proteins; EV, Empty vector; FASP, Filter-aided sample preparation; O/E, Overexpression; PFA, Paraformaldehyde; TNBC, Triple-negative breast cancer.\u003Cbr>Ha-Song Bae, Yun-Jeong Seo, and Eun-Bi Kim contributed equally to this work\u003Cbr>|\n| --- |\n| This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.\u003Cbr>© 2026 The Author(s). Proteomics published by Wiley-VCH GmbH. |\n\n28 Proteomics, 2026; 26:28–41  \n[https://doi.org/10.1002/pm","cbCaiifI3uxdkyVv","https://ap.wps.com/l/cbCaiifI3uxdkyVv","pdf",2750555,14,"English","# Abstract\n# Introduction\n# Significance Statement","[{\"question\":\"What is the main objective of this study on AS1411 and TNBC?\",\"answer\":\"The study investigates the molecular mechanisms behind AS1411’s anticancer effects in triple-negative breast cancer using label-free quantitative proteomics.\"},{\"question\":\"How does AS1411 affect TNBC cells according to the abstract?\",\"answer\":\"AS1411 treatment significantly reduces TNBC cell viability and migration.\"},{\"question\":\"Why is ATP6AP1 important in the findings?\",\"answer\":\"ATP6AP1 is markedly downregulated after AS1411 treatment, and functional experiments show that altering ATP6AP1 expression suppresses or enhances TNBC proliferation and migration, supporting it as a key mediator.\"}]","Proteomic Characterization of AS1411 Reveals ATP6AP1 as a Mediator of Triple-Negative Breast Cancer Progression | PDF",1790129972,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bb7798551758824773a9589c2c4b55b2.webp",983,1283,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cb8ea5e0e5ff2bda58ec711bfdb59aaf.webp",982,1281,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0404ba49c10154fa7e980a16a3f02124.webp",981,1280,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4b0a93db6059fa3404605608616bcac2.webp",980,1279]